Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT07377669
Enrolling by invitation Observational

A Retrospective and Prospective Study: Monocompartimental Knee Arthroplasty Combined With Anterior Cruciate Ligament Reconstruction Surgery - a Pilot Study

NCT07377669 · tracked via the Priya Life Science Italy tracker
Sponsor
Istituto Ortopedico Rizzoli
Phase
Observational
Started
2025-06-01
Last updated
2026-01-30

Condition(s) studied

Knee Arthritis OsteoarthritisCruciate Ligament Rupture

Investigational drug(s) / intervention(s)

UKA + ACLr

UKA + ACLr: Simultaneous ACL reconstruction and Unicompartmental Knee Arthroplasty

Study summary

This study aims to collect datas about patient who underwent simultaneous monocompartimental knee replacement and anterior cruciate ligament recontruction

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria: * monocompartimental knee arthrosis and ACL complete lesion * High functional request * Follow up \>12 m * Complete clinical and radiographic documentation * Patients who accepted to partecipate to the study * Patients who did non underwent surgical procedures in the controlateral knee Exclusion Criteria: * two stage surgeries (UKA and ACLr) * patients affected by neuromuscolar disorders, or psychomotor disorders * further knee ligamentous associated lesions * revision surgery * low functional request due to comorbilities

Primary outcome measure(s)

  • Tegner-Lysholm score — 12 months after surgery
    The Tegner Lysholm Knee Scoring Scale is a questionnaire used to assess knee function and symptoms, particularly in the context of ligament injuries of the knee. It evaluates eight categories: pain, swelling, instability, locking, limp, stair climbing, squatting, and need for support. Each category is scored, and the total score, out of 100, reflects overall knee function. Higher scores indicate better knee function.

Trial sites (1)

FacilityCityRegionStatus
Istituto Ortopedico Rizzoli Bologna Italy

More Istituto Ortopedico Rizzoli trials in Italy

Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis Recruiting
Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery Recruiting
Functional and Morphological Characterization of Multiple Osteochondromas Disorder Recruiting
Knee Osteotomy Associated With Allograft Meniscus Transplantation Recruiting
Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07377669 on ClinicalTrials.gov ↗ ← All trials in Italy